Brief: Mankind Pharma March-Quarter Consol Profit From Continuing Operations 5.59 Billion Rupees
19/05/2026 14:59
May 19 (Reuters) - Mankind Pharma Ltd MNKI.NS: MANKIND PHARMA MARCH-QUARTER CONSOL PROFIT FROM CONTINUING OPERATIONS 5.59 BILLION RUPEES MANKIND PHARMA MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 34.43 BILLION RUPEES MANKIND PHARMA - APPROVED ADDITIONAL INVESTMENT OF UP TO 5 BILLION RUPEES IN MANKIND MEDICARE , IN ONE OR MORE TRANCHES Further company coverage: MNKI.NS ((reuters.briefs@thomsonreuters.com;))
Recent news on Mankind Pharma
See all newsBrief: Mankind Pharma Buys Remaining 10% Stake In Upakarma
India's top condom maker may hike prices on war-linked oil surge
India's Mankind Pharma climbs on strong Q4 profit
Indian drugmaker Mankind posts strong quarterly profit on demand for chronic therapies
Brief: Mankind Pharma March-Quarter Consol Profit From Continuing Operations 5.59 Billion Rupees